Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Determining influenza virus shedding at different time points in madin-darby canine kidney cell line.

Abdoli A, Soleimanjahi H, Tavassoti Kheiri M, Jamali A, Jamaati A.

Cell J. 2013 Summer;15(2):130-5. Epub 2013 Jul 2.

2.

Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line.

Peschel B, Frentzel S, Laske T, Genzel Y, Reichl U.

Vaccine. 2013 Nov 19;31(48):5693-9. doi: 10.1016/j.vaccine.2013.09.051. Epub 2013 Oct 8.

PMID:
24113260
3.

High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7.

Hamamoto I, Takaku H, Tashiro M, Yamamoto N.

PLoS One. 2013;8(3):e59892. doi: 10.1371/journal.pone.0059892. Epub 2013 Mar 26.

5.

Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.

Shin D, Park KJ, Lee H, Cho EY, Kim MS, Hwang MH, Kim SI, Ahn DH.

Virus Res. 2015 Jun 2;204:40-6. doi: 10.1016/j.virusres.2015.04.005. Epub 2015 Apr 17.

PMID:
25892718
6.

Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants.

Isken B, Genzel Y, Reichl U.

Vaccine. 2012 Jul 27;30(35):5253-61. doi: 10.1016/j.vaccine.2012.05.065. Epub 2012 Jun 12.

PMID:
22698452
7.

High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state.

Seitz C, Frensing T, Höper D, Kochs G, Reichl U.

J Gen Virol. 2010 Jul;91(Pt 7):1754-63. doi: 10.1099/vir.0.020370-0. Epub 2010 Mar 31.

PMID:
20357039
8.

Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.

Donis RO; Influenza Cell Culture Working Group, Davis CT, Foust A, Hossain MJ, Johnson A, Klimov A, Loughlin R, Xu X, Tsai T, Blayer S, Trusheim H, Colegate T, Fox J, Taylor B, Hussain A, Barr I, Baas C, Louwerens J, Geuns E, Lee MS, Venhuizen O, Neumeier E, Ziegler T.

Vaccine. 2014 Nov 12;32(48):6583-90. doi: 10.1016/j.vaccine.2014.06.045. Epub 2014 Jun 24.

9.

Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.

Suzuki T, Takahashi T, Guo CT, Hidari KI, Miyamoto D, Goto H, Kawaoka Y, Suzuki Y.

J Virol. 2005 Sep;79(18):11705-15.

10.

Comparison between MDCK and MDCK-SIAT1 cell lines as preferred host for cell culture-based influenza vaccine production.

Abdoli A, Soleimanjahi H, Jamali A, Mehrbod P, Gholami S, Kianmehr Z, Feizi N, Saleh M, Bahrami F, Mokhtari-Azad T, Abdoli M, Kheiri MT.

Biotechnol Lett. 2016 Jun;38(6):941-8. doi: 10.1007/s10529-016-2069-4. Epub 2016 Mar 5.

PMID:
26945752
11.

Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor.

Chu C, Lugovtsev V, Lewis A, Betenbaugh M, Shiloach J.

Vaccine. 2010 Oct 18;28(44):7193-201. doi: 10.1016/j.vaccine.2010.08.059. Epub 2010 Aug 26.

PMID:
20800699
12.

Mathematical model of influenza A virus production in large-scale microcarrier culture.

Möhler L, Flockerzi D, Sann H, Reichl U.

Biotechnol Bioeng. 2005 Apr 5;90(1):46-58.

PMID:
15736163
14.

Anti-influenza A virus activity of uridine derivatives of 2-deoxy sugars.

Krol E, Wandzik I, Gromadzka B, Nidzworski D, Rychlowska M, Matlacz M, Tyborowska J, Szewczyk B.

Antiviral Res. 2013 Oct;100(1):90-7. doi: 10.1016/j.antiviral.2013.07.014. Epub 2013 Aug 1.

PMID:
23911991
15.

Impact of cultivation conditions on N-glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture.

Rödig JV, Rapp E, Bohne J, Kampe M, Kaffka H, Bock A, Genzel Y, Reichl U.

Biotechnol Bioeng. 2013 Jun;110(6):1691-703. doi: 10.1002/bit.24834. Epub 2013 Feb 4.

PMID:
23297157
16.

Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.

Genzel Y, Olmer RM, Schäfer B, Reichl U.

Vaccine. 2006 Aug 28;24(35-36):6074-87. Epub 2006 Jun 2.

PMID:
16781022
17.

Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin.

Roedig JV, Rapp E, Höper D, Genzel Y, Reichl U.

PLoS One. 2011;6(12):e27989. doi: 10.1371/journal.pone.0027989. Epub 2011 Dec 7.

18.

Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.

van Wielink R, Kant-Eenbergen HC, Harmsen MM, Martens DE, Wijffels RH, Coco-Martin JM.

J Virol Methods. 2011 Jan;171(1):53-60. doi: 10.1016/j.jviromet.2010.09.029. Epub 2010 Oct 7.

PMID:
20933017
19.

The growth of attenuated influenza vaccine donor strains in continuous cell lines.

Audsley JM, Tannock GA.

J Virol Methods. 2005 Feb;123(2):187-93.

PMID:
15620401
20.

Comparative study of influenza virus replication in Vero and MDCK cell lines.

Youil R, Su Q, Toner TJ, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Kiseleva I, Shaw AR, DiStefano D.

J Virol Methods. 2004 Sep 1;120(1):23-31.

PMID:
15234806

Supplemental Content

Support Center